The liver function of patients with suspected liver disease is poor, as demonstrated by the patient’s jaundice—an inability to conjugate bilirubin. Importantly, because some liver products are blood-clotting factors involved in the clotting cascade, the blood-clotting ability of patients with severe liver disease is significantly impaired. These patients therefore have a high risk of bleeding.
Another issue is the presence of ascites.